• Protease Inhibitor Cocktail for Ferroptosis Assays

  2026-08-25

  Learn how a Protease Inhibitor Cocktail EDTA-Free can improve protein-level readouts in AML ferroptosis research. This assay-focused guide connects ACSL4-driven lipid remodeling with practical lysate preservation, phosphorylation analysis, and endpoint selection.

• CUDC-907 Protocol and QC Guide

  2026-08-25

  CUDC-907 is a dual PI3K and HDAC inhibitor for controlled cell-based studies of PI3K/AKT signaling, epigenetic regulation, cell-cycle progression, and apoptosis. This guide covers dossier-based handling and workflow controls; it is not a clinical, diagnostic, or therapeutic protocol.

• Sumatriptan Succinate: Mechanism & Research Use

  2026-08-24

  Sumatriptan Succinate is a selective 5-HT1 receptor agonist with established relevance to migraine research and serotonergic signaling research. Evidence supports 5-HT1B/1D-mediated neurovascular effects, while pediatric emergency data support intranasal use as a feasible pathway treatment rather than a universally proven standard.

• Sisomicin: Mechanism, Evidence, and Research Use

  2026-08-24

  Sisomicin is a broad-spectrum aminoglycoside antibiotic that inhibits bacterial protein synthesis through interaction with the 30S ribosomal subunit. Its research use spans in vitro antibacterial testing, animal infection models, and avian inner-ear experiments, but susceptibility, renal function, ototoxicity, and nephrotoxicity require context-specific interpretation.

• KN-62 CaMKII Inhibition: Evidence & Use

  2026-08-23

  KN-62, also known as 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine, is a research inhibitor of calcium/calmodulin-dependent protein kinase II. Product information reports a CaMKII Ki of 0.9 μM and applications spanning secretion, skeletal-muscle glucose transport, and K562 cell-cycle studies.

• Cannabidiol in Orofacial Inflammatory Pain: Study Analysis

  2026-08-22

  This 2026 Brain Research Bulletin study shows that cannabidiol (CBD) can reduce inflammatory pain while also improving affective and cognitive abnormalities in mouse models. Its central innovation is a multi-level analysis linking peripheral cannabinoid signaling, trigeminal and cortical neuronal activity, endocannabinoid changes, and serotonin dynamics in the central amygdala.

• Viral RIPK3 Degradation and Inflammation

  2026-08-21

  The Immunity study identified a conserved orthopoxvirus factor, vIRD, that recruits SCF machinery to ubiquitinate and degrade RIPK3, suppressing necroptosis while enhancing viral fitness. Its genetic and infection-model evidence shows that viral manipulation of host protein degradation can simultaneously shape inflammation, replication, and disease severity.

• Fluoxetine HCl: Reproducible Cell Assays

  2026-08-21

  Learn how Fluoxetine HCl (SKU A2436) can support reproducible cell-based studies of serotonergic signaling, receptor function, proliferation, and viability. This scenario-driven guide distinguishes pathway activity from cytotoxicity and provides practical handling, concentration-selection, interpretation, and vendor-evaluation guidance.

• Ziprasidone Augmentation in Anxious Depression

  2026-08-20

  This post-hoc moderator analysis examined whether baseline anxious depression changed the response to ziprasidone added to escitalopram in patients with major depressive disorder. Depression improvement did not differ significantly between anxiety subgroups, while the numerical anxiety benefit in more anxious patients was small and not clinically meaningful, emphasizing the need to separate symptom-domain effects in antidepressant research.

• Quercetin: From PI3K Signals to NLRP3 Evidence

  2026-08-20

  Quercetin is a context-dependent PI3K inhibitor and anti-inflammatory agent whose effects extend from mitochondrial apoptosis to microglial inflammasome signaling. This article presents an evidence-layered strategy for interpreting quercetin experiments across cancer research and neuroinflammation without confusing pathway convergence with target specificity.

• Tropisetron Hydrochloride: Applied Workflows

  2026-08-19

  Tropisetron Hydrochloride supports a paired strategy for studying 5-HT3 receptor signaling, α7-nicotinic receptor activity, and renal organic-cation transport. This guide translates its dual pharmacology into practical receptor, OCT2, MATE1, and transcellular assay workflows with troubleshooting guidance.

• Sumatriptan: From Receptor Probe to Assay Design

  2026-08-19

  Sumatriptan Succinate is more than a migraine research compound: it is a context-sensitive 5-HT1 receptor agonist whose metabolites can reshape assay interpretation. This guide connects receptor pharmacology, neurogenic inflammation, and the updated CYP–MAO metabolism evidence to practical experimental design.

• Reversine: Aurora Kinase Inhibitor Workflow Guide

  2026-08-18

  Reversine (SKU A3760) provides a dossier-defined Aurora kinase inhibitor for controlled studies of mitotic regulation, cell-cycle behavior, cancer cell proliferation inhibition, and apoptosis-related endpoints. This guide covers preparation, assay planning, and quality control; the compound is for scientific research only and should not be used for diagnosis, treatment, or other clinical purposes.

• WAY-100635: A Translational 5-HT1A Lens

  2026-08-18

  WAY-100635 gives translational researchers a selective, mechanistically clean way to test whether 5-HT1A signaling contributes to pain, affective dysfunction, and serotonergic circuit activity. This article connects receptor pharmacology with the 2026 cannabidiol study on orofacial inflammatory pain and outlines how to move from binding assays to behavioral and imaging hypotheses.

• NMDA: Designing Glaucoma Excitotoxicity Assays

  2026-08-17

  NMDA (N-Methyl-D-aspartic acid) can do more than induce neuronal injury: it can help connect receptor-driven calcium loading with oxidative stress and ferroptosis phenotypes. This guide translates a retinal glaucoma study into a tiered, decision-focused assay strategy.

7885 records 1/526 page Next 12345 下5页 Last page